Accounts Receivable, after Allowance for Credit Loss, Current in USD of THERALINK TECHNOLOGIES, INC. from Q1 2011 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
Summary
THERALINK TECHNOLOGIES, INC. quarterly Accounts Receivable, after Allowance for Credit Loss, Current history and change rate from Q1 2011 to Q4 2023.
  • THERALINK TECHNOLOGIES, INC. Accounts Receivable, after Allowance for Credit Loss, Current for the quarter ending 31 Dec 2023 was $45.8K, a 5.21% decline year-over-year.
Accounts Receivable, after Allowance for Credit Loss, Current, Quarterly (USD)
Accounts Receivable, after Allowance for Credit Loss, Current, YoY Quarterly Change (%)

THERALINK TECHNOLOGIES, INC. Quarterly Accounts Receivable, after Allowance for Credit Loss, Current (USD)

Period Value YoY Chg Change % Date Report Filed
Q4 2023 $45.8K -$2.52K -5.21% 31 Dec 2023 10-Q 20 Feb 2024
Q3 2023 $23.9K -$8.22K -25.6% 30 Sep 2023 10-Q 20 Feb 2024
Q2 2023 $15K -$94.4K -86.3% 30 Jun 2023 10-Q 21 Aug 2023
Q1 2023 $40.6K -$96.4K -70.4% 31 Mar 2023 10-Q 15 May 2023
Q4 2022 $48.3K -$1.43K -2.88% 31 Dec 2022 10-Q 21 Feb 2023
Q3 2022 $32.1K 30 Sep 2022 10-K 05 Jan 2024
Q2 2022 $109K -$40.6K -27.1% 30 Jun 2022 10-Q 15 Aug 2022
Q1 2022 $137K +$80.5K +142% 31 Mar 2022 10-Q 23 May 2022
Q4 2021 $49.7K 31 Dec 2021 10-Q 18 Feb 2022
Q2 2021 $150K +$125K +500% 30 Jun 2021 10-Q 28 Sep 2021
Q1 2021 $56.5K 31 Mar 2021 10-Q 27 Sep 2021
Q2 2020 $25K 30 Jun 2020 10-Q 11 Jun 2021
Q3 2019 $4K 30 Sep 2019 10-Q 11 Jun 2021
Q3 2017 $93.4K 30 Sep 2017 10-Q 20 Nov 2017
Q2 2017 $94.1K 30 Jun 2017 10-Q 14 Sep 2017
Q1 2017 $170K 31 Mar 2017 10-Q 22 May 2017
Q2 2013 $0 -$94.1K -100% 31 May 2013 10-Q 31 Jul 2013
Q1 2013 $50.6K -$56.1K -52.6% 28 Feb 2013 10-Q 31 Jul 2013
Q4 2012 $40.2K -$15.9K -28.3% 30 Nov 2012 10-Q 22 Jan 2013
Q3 2012 $65.7K +$35.1K +115% 31 Aug 2012 10-Q 15 Oct 2012
Q2 2012 $94.1K 31 May 2012 10-Q 13 Jul 2012
Q1 2012 $107K +$51.6K +93.6% 29 Feb 2012 10-K 28 Jun 2013
Q4 2011 $56.1K 30 Nov 2011 10-Q 17 Jan 2012
Q3 2011 $30.6K 31 Aug 2011 10-Q 17 Oct 2011
Q1 2011 $55.1K 28 Feb 2011 10-K 18 May 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.